FDA Advisory Committee votes in favour of the clinical
U.S. FDA’s Oncologic Drugs Advisory Committee voted 11 to 2 in favour of the clinical benefit of the phase III POLARIX
Globe Newswire10-03-2023, 06:48
Gorilla Technology to Announce Full Year 2022 Results and Host Conference Call 31-03-2023, 23:00